Back to results
US 11,781,167 B2Granted
Continuous glucose monitoring using an FAD-dependent glucose dehydrogenase
AssigneeKikkoman Corporation
InventorYosuke Masakari
Life of this patent
Estimating the term…
Abstract
Provided is a method of continuous glucose monitoring (CGM) comprising using an FAD-GDH. The FAD-GDH is capable of retaining initial activity over a certain period of time. Also provided is a method for screening for an FAD-GDH suitable for use in CGM as well as a CGM device comprising an FAD-GDH.
Claims4
A method of continuous glucose monitoring comprising using a glucose dehydrogenase (GDH) capable of
- (a) retaining 60% or more of the initial activity over a period of 1 week when retained at 40° C. in solution when retained at a pH of 7.4,
- (b) retaining 40% or more of the initial activity over a period of 2 weeks when retained at 40° C. in solution when retained at a pH of 7.4, or
- (c) retaining 30% or more of the initial activity over a period of 3 weeks when retained at 40° C. in solution when retained at a pH of 7.4,
- wherein said GDH is a flavin adenine dinucleotide (FAD) dependent GDH and wherein said GDH is neither a membrane bound protein nor GLD3,
- wherein the continuous glucose monitoring comprises
- i) bringing a sample containing glucose into contact with a glucose sensor, wherein the glucose sensor comprises an electrode, the GDH and a mediator, wherein the GDH is immobilized on the electrode and wherein the mediator is immobilized on the electrode,
- ii) applying a potential to the electrode, and
- iii) measuring the response current,
- wherein the continuous glucose monitoring is carried out for 1 day or more.
6 more elements
Dependencies are inferred from the claim text.